Omnilink Elite is a next generation Cobalt Chromium stent proven in challenging iliac cases.1 The Cobalt Chromium and Multi-Link design create a strong yet highly flexible stent that conforms to tortuous anatomies.
1 Adapted from “Modern Endovascular Management of Patients with Iliac Artery Disease. Results from the MOBILITY Trial”, M Jaff, SCAI 2012
ELITE ENGINEERINGState of the Art Stent Design
ELITE PERFORMANCEHigh Performance Catheter
Proven in Complex Patients
1. The ISAR-STEREO and ISAR-STEREO-2 trials studied stents designed with Multi-Link technology.
Kastrati, et al. Intracoronary stenting and angiographic results strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 2001; 103:2816-2821.
Pache, et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. JACC 2003; 41:1283-8.
Kolandaivelu et al. Stent thrombogenecity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer- drug coating. Circulation 2011; 1400-1408.
2. -1.81% shortening for 8.0 x 39 mm size. Tests performed by and data on file at Abbott Vascular.
3. Adapted from “Modern Endovascular Management of Patients with Iliac Artery Disease. Results from the MOBILITY Trial”, M Jaff, SCAI 2012
* WIQ was used to assess walking distance, walking speed and stair climbing for study subjects.
AP2946450-WBO Rev. A
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.